Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

SZSE:002118 Stock Report

Market Cap: CN¥473.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Jilin Zixin Pharmaceutical IndustrialLtd Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Youshun Feng

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure1.3yrs

Recent management updates

Recent updates

CEO

Youshun Feng (43 yo)

4.3yrs

Tenure

CN¥508,200

Compensation

Mr. Youshun Feng serves as Non-Independent Director of Jilin Zixin Pharmaceutical Industrial Co.,Ltd since May 21, 2019. He serves as Chairman, General Manager and Board Secretary at Jilin Zixin Pharmaceut...

Board Members

NamePositionTenureCompensationOwnership
Youshun Feng
Chairman4.3yrsCN¥508.20kno data
Li Li Sun
CFO & Chairman of Supervisory Board1.3yrsno datano data
Yan Cheng
Independent Director4.3yrsCN¥50.00kno data
Yueying Ren
Independent Director4.3yrsCN¥50.00kno data
Zhonghai Yan
Independent Director4.3yrsCN¥50.00kno data
Xiyuan Yin
Non-Independent Director1.3yrsno datano data
Xuan Lu
Non-Independent Director1.3yrsno datano data
Feng Tian
Non-Independent Director1.3yrsCN¥303.70kno data
Fu Chen
Non-Independent Directorless than a yearno datano data
Meng Xiangjin
Directorless than a yearno datano data
Sun Lili
Directorless than a yearno datano data
Xu Wenqing
Directorless than a yearno datano data

1.3yrs

Average Tenure

50yo

Average Age

Experienced Board: 002118's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/08/05 18:43
End of Day Share Price 2023/06/15 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jilin Zixin Pharmaceutical Industrial Co.,Ltd. is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
YANG QIAOChangjiang Securities Co. LTD.
Qiu Han HuangSealand Securities